Galapagos and Servier report topline results for ROCCELLA Phas...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
MECHELEN, Belgium and PARIS, Oct. 15, 2020 /PRNewswire-AsiaNet/ -- Servier and Galapagos NV report that no signal of activity was observed in the topline results in their ROCCELLA Phase 2 trial with GLPG1972/S201086. ROCCELLA is a global, double-blind, placebo-controlled, dose ranging trial evaluating the eff...
Authors: LATEST ASIANET NEWS RELEASES